BUSINESS3 years ago
Lexaria Bioscience Corp (NASDAQ: LEXX) Release HYPER-H12-1 Study Results And Avails DehydraTECH in The US
Lexaria Bioscience Corp (NASDAQ: LEXX) has released partial results from HYPER-H12-1 human clinical trial evaluating DehhydraTech processed CBD as a potential hypertension application. Partial results linked...